Request An Appointment
816-836-2200
Kansas City's Premiere Digestive Health Specialists
Request An Appointment
816-836-2200
Kansas City's Premiere Digestive Health Specialists
New hope and treatment option for patients with Barrett’s Esophagus at Midwest Gastroenterology Partners.
Patients diagnosed with gastroesophageal reflux disease (GERD) are at risk for developing Barrett’s Esophagus. Barrett’s Esophagus is a pre-cancerous condition caused by inflammation and genetic changes in the lining of the esophagus. Treatments for this condition include endosopic and surgical therapy such as the HALO ablation technology.
Ablation therapy is a technique that uses targeted heat to destroy abnormal or diseased tissue. The HALO ablation technology is a very specific type of ablation that delivers heat energy in a precise and very-controlled manner. The HALO procedure provides complete removal of the diseased tissue in the esophagus without damaging normal underlying structures. Clinical studies have demonstrated the Barrett’s tissue is completely eliminated with the HALO ablation technology in 98.4% of patients.
